PASQUALI, Micol
 Distribuzione geografica
Continente #
NA - Nord America 5.256
AS - Asia 2.875
EU - Europa 1.894
SA - Sud America 491
AF - Africa 58
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.594
Nazione #
US - Stati Uniti d'America 5.119
SG - Singapore 1.053
CN - Cina 765
IT - Italia 438
BR - Brasile 394
VN - Vietnam 341
PL - Polonia 329
DE - Germania 254
UA - Ucraina 211
HK - Hong Kong 202
GB - Regno Unito 167
TR - Turchia 131
FI - Finlandia 116
JP - Giappone 88
SE - Svezia 85
IN - India 80
FR - Francia 69
CA - Canada 63
RU - Federazione Russa 63
MX - Messico 58
ID - Indonesia 43
AR - Argentina 40
BD - Bangladesh 33
ZA - Sudafrica 27
ES - Italia 23
IQ - Iraq 23
NL - Olanda 23
BE - Belgio 20
AU - Australia 18
BG - Bulgaria 17
UZ - Uzbekistan 15
CH - Svizzera 14
CZ - Repubblica Ceca 14
VE - Venezuela 14
AT - Austria 12
EC - Ecuador 12
IR - Iran 11
PK - Pakistan 11
TW - Taiwan 10
CO - Colombia 9
HU - Ungheria 8
JO - Giordania 8
LT - Lituania 8
MY - Malesia 8
PH - Filippine 8
BO - Bolivia 7
AE - Emirati Arabi Uniti 5
CL - Cile 5
MA - Marocco 5
PY - Paraguay 5
AZ - Azerbaigian 4
IE - Irlanda 4
KE - Kenya 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
PA - Panama 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
Totale 10.587
Città #
Singapore 696
Ashburn 486
San Jose 378
Woodbridge 378
Ann Arbor 354
Warsaw 327
Fairfield 307
Houston 268
Chandler 249
Jacksonville 242
Beijing 228
Santa Clara 209
Hong Kong 196
Ferrara 156
Wilmington 111
Seattle 110
The Dalles 109
Nanjing 105
Ho Chi Minh City 92
Cambridge 91
Izmir 85
Hanoi 81
Los Angeles 81
Tokyo 80
Addison 72
Munich 72
Dallas 67
New York 63
Princeton 60
Boardman 58
Dong Ket 57
São Paulo 50
Lauterbourg 49
Milan 47
Dearborn 46
Helsinki 42
Mexico City 40
Shanghai 34
Redwood City 32
Turku 30
Orem 29
San Diego 29
Bologna 28
Buffalo 28
Nanchang 28
Shenyang 28
London 24
Tianjin 23
Jakarta 22
Montreal 21
Stockholm 21
Denver 20
Council Bluffs 19
Chennai 18
Legnaro 18
Frankfurt am Main 17
Guangzhou 17
Johannesburg 17
Phoenix 17
Boston 16
Hebei 16
Atlanta 15
Brussels 15
Moscow 15
Nuremberg 15
Rio de Janeiro 15
Toronto 15
Bremen 14
Changsha 14
Chicago 14
Tashkent 14
Brooklyn 13
Falls Church 13
Belo Horizonte 12
Da Nang 12
Kunming 12
Poplar 12
Brno 11
Haiphong 11
San Francisco 11
Amsterdam 10
Jiaxing 10
Auburn Hills 9
Baghdad 9
Des Moines 9
Hefei 9
New Delhi 9
Ningbo 9
Brasília 8
Las Vegas 8
Mumbai 8
Ottawa 8
Reinach 8
Taizhou 8
Augusta 7
Basingstoke 7
Buenos Aires 7
Columbus 7
Curitiba 7
Monmouth Junction 7
Totale 7.111
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 514
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 388
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 335
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 317
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 287
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 286
A solvent-extraction module for cyclotron production of high-purity technetium-99m 273
LARAMED: A Laboratory for Radioisotopes of Medical Interest 270
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 249
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 232
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 225
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 220
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 213
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 209
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 205
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 204
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 196
Extraction techniques of 99mTc from 100Mo Metal Target 196
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 192
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 189
Development of a β-spectrometer for 99gTc Activity Estimations 184
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 179
188W/188Re generator system and its therapeutic applicacions 177
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 176
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 173
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 172
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 171
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 166
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 166
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 162
Technetium complexes and radiopharmaceuticals with scorpionate ligands 154
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 153
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 152
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 147
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 147
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 145
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 142
Production of 47Sc with natural vanadium targets: results of the PASTA project 141
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 138
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 138
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 138
LABELLING OF SMALL MOLECULES WITH THE 99mTc-NITRIDO CORE (cap.15) 132
LABELLING OF BIOTIN WITH 188Re 127
New [3+1] Chelating System for Rhenium (V) Nitrido Radiopharmaceuticals 125
Quality control of Tc-99m radiopharmaceuticals: influence of the generator in growth time on the final radiochemical purity 124
Might Re-188 be more effective for boosting therapy of breast cancer using the IART approach? 122
Synthesis, characterizition ad X-ray crystal structure of the trigonal-planar copper (1) complex [Cu(MIBI)(3)](+) (MIBI=2-methoxyisobutylisocyanide) 121
New "3+1" chelating system for the development of therapeutic agents labeled with rhenium-188 121
New "3+1" chelating system for the development of therapeutic agents lebeled with rhenium-188. 121
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of Nitrido 99mTc and 188Re radiopharmaceuticals 120
PEGylated N-methly-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of Nitrido99mTc and 188Re radiopharmaceuticals 118
In vivo evaluation of nanostructured lipid labelled with 99mTc 118
Novel Tc-99m radiotracer for brain imaging 117
Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P 116
null 109
Production of 67Cu by enriched 70Zn targets: First measurements of formation cross sections of 67Cu, 64Cu, 67Ga, 66Ga, 69mZn and 65Zn in interactions of 70Zn with protons above 45 MeV 107
Development of an automatic separation/extraction module for the accelerator 99mTc production from 100Mo enriched molybdenum metal targets 106
null 102
Metodo e bersaglio per la produzione di 67Cu A method and a target for the production of 67Cu 78
null 60
null 48
Totale 10.713
Categoria #
all - tutte 41.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.303
Totale 46.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 0 124 89
2021/2022652 35 56 48 33 21 34 39 34 26 54 76 196
2022/2023560 64 61 11 75 84 80 35 47 43 9 34 17
2023/2024350 27 44 26 13 22 38 17 24 11 14 10 104
2024/20251.755 49 38 115 53 159 101 56 96 249 171 506 162
2025/20263.777 392 134 290 518 614 290 541 231 355 401 11 0
Totale 10.713